Trial Profile
Effects of ABT 122 on TNF and IL-17 activity in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 28 Jan 2017
Price :
$35
*
At a glance
- Drugs Remtolumab (Primary)
- Indications Rheumatoid arthritis
- Focus Pharmacodynamics
- 23 Jul 2015 New trial record
- 13 Jun 2015 Results presented at the 16th Annual Congress of the European League Against Rheumatism.